Demonstrates the value adding proposition that FPP technology contributes to improving the efficacy of leading therapies in development like Omomyc. But clearly, the data is tempting in terms of what it could potentially add to the life and value of some of the world's current high dollar value oncology drugs. This is possibly a source of the NDAs the company has engaged with this year, but that is purely speculation on my part.
Demonstrates the value adding proposition that FPP technology...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |